BridgeMD
New treatment option for Attention Deficit Hyperactivity Disorder
Official title Mindfulness Intervention for College Students With ADHD
ClinicalTrials.gov ID: NCT06076967
What this study is testing
- What it's testing
- Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention for first-year college students with ADHD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 17 to 25
You may be able to join if
- First-semester college student with ADHD
- Age 17-25
- Must meet criteria for ADHD
- No major medical problems
You likely can't join if
- Severe depression
- Mania
- Ongoing substance abuse
- Personality disorder that may interfere with group delivery
- Psychotic symptoms
- Recent history of trauma
See the full eligibility criteria
- First-semester college student with ADHD
- Age 17-25
- Must meet criteria for ADHD
- No major medical problems
- Severe depression
- Mania
- Ongoing substance abuse
- Personality disorder that may interfere with group delivery
- Psychotic symptoms
- Recent history of trauma
- Unstable dosage of psychotropic medication
The study team makes the final eligibility decision.
Where it's taking place
- Tuscaloosa, Alabama, United States
- Spartanburg, South Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 17 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tuscaloosa, Alabama, United States; Spartanburg, South Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.